Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 11—November 2025

Research Letter

Molecular Evidence of Dengue Virus Serotype 2 in Travelers Returning to Israel from the Sinai Peninsula

Neta S. Zuckerman1Comments to Author , Guy Choshen1, Yaniv Lustig, Anna Shoykhet, Keren Friedman, Tatyana Kushnir, Ora Halutz, Hovav Azulay, Victoria Indenbaum1, and Eli Schwartz1
Author affiliation: Sheba Medical Center, Ramat-Gan, Israel (N.S. Zuckerman, Y. Lustig, K. Friedman, T. Kushnir, V. Indenbaum, E. Schwartz); Tel-Aviv University, Tel Aviv, Israel (G. Choshen, Y. Lustig, O. Halutz, E. Schwartz); Meir Medical Center, Kfar-Saba, Israel (G. Choshen, A. Shoykhet); Infectious Disease Institute, Soroka University Medical Center, Beer Sheba, Israel (H. Azulay)

Main Article

Figure

Epidemiology, phylogeny, and geography of dengue virus (DENV) serotype 2 (DENV-2) circulation in the Red Sea region in study of molecular evidence of DENV-2 emergence from travelers returning to Israel from the Sinai Peninsula. A) Phylogenetic analysis of DENV-2 whole-genome sequences. Phylogenetic tree was constructed using the samples from Israel sequenced in this study (n = 3) alongside global DENV-2 sequences from the past decade (n = 1,492) available in the DENV-2 Nextstrain build (https://nextstrain.org/dengue/denv2/genome). The radial tree illustrates the global DENV-2 genotypes, highlighting the Israel sequences (n = 3, circled) within the broader dataset. Nodes are color-coded by DENV genotype. The cluster marked by a black arc is magnified in the right portion. The rectangular tree focuses on the cluster containing the Israeli sequences (n = 3), showing the genetic divergence within the group. Nodes are color-coded by the country of origin, and the number of mutations connecting the Israeli cluster to the nearest ancestor is indicated in parentheses. B) Dengue fever outbreak locations, including the current outbreak in Sharm El-Sheikh (star) and outbreaks reported in the region in recent years (black circles labeled by year): Jeddah 2006 (3), El-Quseir 2017 (4), Port Sudan 2019 (5), Jizan 2022 (6), and Hurghada 2023 (7).

Figure. Epidemiology, phylogeny, and geography of dengue virus (DENV) serotype 2 (DENV-2) circulation in the Red Sea region in study of molecular evidence of DENV-2 emergence from travelers returning to Israel from the Sinai Peninsula. A) Phylogenetic analysis of DENV-2 whole-genome sequences. Phylogenetic tree was constructed using the samples from Israel sequenced in this study (n = 3) alongside global DENV-2 sequences from the past decade (n = 1,492) available in the DENV-2 Nextstrain build (https://nextstrain.org/dengue/denv2/genome). The radial tree illustrates the global DENV-2 genotypes, highlighting the Israel sequences (n = 3, circled) within the broader dataset. Nodes are color-coded by DENV genotype. The cluster marked by a black arc is magnified in the right portion. The rectangular tree focuses on the cluster containing the Israeli sequences (n = 3), showing the genetic divergence within the group. Nodes are color-coded by the country of origin, and the number of mutations connecting the Israeli cluster to the nearest ancestor is indicated in parentheses. B) Dengue fever outbreak locations, including the current outbreak in Sharm El-Sheikh (star) and outbreaks reported in the region in recent years (black circles labeled by year): Jeddah 2006 (3), El-Quseir 2017 (4), Port Sudan 2019 (5), Jizan 2022 (6), and Hurghada 2023 (7).

Main Article

References
  1. World Health Organization. Dengue and severe dengue [2025 Mar 1]. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.
  2. Santiago  GA, Vergne  E, Quiles  Y, Cosme  J, Vazquez  J, Medina  JF, et al. Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl Trop Dis. 2013;7:e2311. DOIPubMedGoogle Scholar
  3. Kholedi  AAN, Balubaid  O, Milaat  W, Kabbash  IA, Ibrahim  A. Factors associated with the spread of dengue fever in Jeddah Governorate, Saudi Arabia. East Mediterr Health J. 2012;18:1523. DOIPubMedGoogle Scholar
  4. El-Kady  AM, Osman  HA, Alemam  MF, Marghani  D, Shanawaz  MA, Wakid  MH, et al. Circulation of dengue virus serotype 2 in humans and mosquitoes during an outbreak in El Quseir City, Egypt. Infect Drug Resist. 2022;15:271321. DOIPubMedGoogle Scholar
  5. Desogi  M, Ali  M, Gindeel  N, Khalid  F, Abdelraheem  M, Alnaby  A, et al. Detection of dengue virus serotype 4 in Sudan. East Mediterr Health J. 2023;29:43641. DOIPubMedGoogle Scholar
  6. Dafalla  O, Abdulhaq  AA, Almutairi  H, Noureldin  E, Ghzwani  J, Mashi  O, et al. The emergence of an imported variant of dengue virus serotype 2 in the Jazan region, southwestern Saudi Arabia. Trop Dis Travel Med Vaccines. 2023;9:5. DOIPubMedGoogle Scholar
  7. Frank  C, Lachmann  R, Wilking  H, Stark  K. Increase in dengue fever in travellers returning from Egypt, Germany 2023. Euro Surveill. 2024;29:2400042. DOIPubMedGoogle Scholar
  8. Manciulli  T, Zammarchi  L, Lagi  F, Fiorelli  C, Mencarini  J, Fognani  M, et al. Emergence of dengue fever: sentinel travellers uncover outbreak in Sharm El-Sheikh, Egypt, May 2024. J Travel Med. 2024;31:taae080. DOIGoogle Scholar
  9. Newman  EA, Feng  X, Onland  JD, Walker  KR, Young  S, Smith  K, et al. Defining the roles of local precipitation and anthropogenic water sources in driving the abundance of Aedes aegypti, an emerging disease vector in urban, arid landscapes. Sci Rep. 2024;14:2058. DOIPubMedGoogle Scholar
  10. El-Kafrawy  SA, Sohrab  SS, Ela  SA, Abd-Alla  AM, Alhabbab  R, Farraj  SA, et al. Multiple introductions of dengue 2 virus strains into Saudi Arabia from 1992 to 2014. Vector Borne Zoonotic Dis. 2016;16:3919. DOIPubMedGoogle Scholar

Main Article

1These authors contributed equally to this article.

Page created: September 18, 2025
Page updated: December 04, 2025
Page reviewed: December 04, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external